Free Trial

Renalytix (RNLX) Short Interest Ratio & Short Volume

$0.35
-0.02 (-5.42%)
(As of 07/12/2024 ET)

Renalytix Short Interest Data

Current Short Interest
292,900 shares
Previous Short Interest
236,600 shares
Change Vs. Previous Month
+23.80%
Dollar Volume Sold Short
$67,659.90
Short Interest Ratio
1.0 Days to Cover
Last Record Date
June 30, 2024
Outstanding Shares
77,180,000 shares
Percentage of Shares Shorted
0.38%
Today's Trading Volume
5,121,459 shares
Average Trading Volume
4,661,156 shares
Today's Volume Vs. Average
110%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Renalytix ?

Sign up to receive the latest short interest report for Renalytix and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RNLX Short Interest Over Time

RNLX Days to Cover Over Time

RNLX Percentage of Float Shorted Over Time

Renalytix Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/2024292,900 shares $67,659.90 +23.8%N/A1 $0.23
6/15/2024236,600 shares $120,169.14 -49.1%N/A0.9 $0.51
5/31/2024464,900 shares $192,840.52 +4.1%N/A1.7 $0.41
5/15/2024446,600 shares $253,222.20 -28.8%N/A0.6 $0.57
4/30/2024627,400 shares $435,352.86 -6.9%N/A0.3 $0.69
4/15/2024673,700 shares $567,659.62 -15.3%N/A0.4 $0.84
3/31/2024795,200 shares $683,872.00 -11.1%N/A0.4 $0.86
3/15/2024894,600 shares $769,356.00 +78.7%N/A0.5 $0.86
2/29/2024500,600 shares $585,702.00 -60.6%N/A0.3 $1.17
2/15/20241,270,000 shares $997,331.00 +111.0%N/A1 $0.79
1/31/2024601,800 shares $190,650.24 -10.5%N/A2.3 $0.32
1/15/2024672,200 shares $215,104.00 +145.3%N/A3.3 $0.32
12/31/2023274,000 shares $106,860.00 +350.7%N/A2.1 $0.39
12/15/202360,800 shares $22,204.16 -68.9%N/A0.5 $0.37
11/30/2023195,500 shares $92,862.50 -11.5%N/A1.9 $0.48
11/15/2023221,000 shares $130,611.00 -36.5%N/A2.3 $0.59
10/31/2023347,800 shares $361,712.00 +65.6%N/A4.4 $1.04
10/15/2023210,000 shares $243,600.00 +32.4%N/A2.7 $1.16
9/30/2023158,600 shares $253,760.00 -69.2%N/A1.7 $1.60
9/15/2023514,700 shares $1.09 million +4.8%N/A0.8 $2.11
8/31/2023491,000 shares $1.42 million +10.2%N/A0.8 $2.90
8/15/2023445,700 shares $1.14 million -3.8%N/A0.7 $2.55
7/31/2023463,400 shares $1.34 million -40.4%N/A0.7 $2.90
7/15/2023777,400 shares $2.92 million +123.2%N/A1.2 $3.76
6/30/2023348,300 shares $1.02 million -6.5%N/A0.6 $2.92
6/15/2023372,400 shares $871,416.00 -3.3%N/A8.1 $2.34
5/31/2023385,200 shares $943,740.00 +44.9%N/A8.3 $2.45
5/15/2023265,900 shares $582,321.00 -20.0%N/A6.6 $2.19
4/30/2023332,500 shares $788,025.00 +7.7%N/A7.5 $2.37
4/15/2023308,600 shares $765,328.00 +52.6%N/A6.2 $2.48
3/31/2023202,300 shares $489,566.00 +43.6%N/A4.1 $2.42
3/15/2023140,900 shares $324,070.00 +17.9%N/A2.5 $2.30
2/28/2023119,500 shares $423,902.35 -42.5%N/A2.3 $3.55
2/15/2023207,900 shares $685,924.47 -32.3%N/A3.7 $3.30
1/31/2023307,200 shares $915,456.00 -17.6%N/A4.8 $2.98
1/15/2023372,900 shares $976,998.00 +0.7%N/A4.1 $2.62
12/30/2022370,400 shares $692,648.00 -8.6%N/A3.8 $1.87
12/15/2022405,300 shares $656,586.00 -7.8%N/A4.1 $1.62
11/30/2022439,700 shares $892,591.00 +6.1%N/A4 $2.03
11/15/2022414,300 shares $592,449.00 -39.7%N/A3.6 $1.43
I’ve seen this situation a handful of times in my life (Ad)

The stock is now trading for just $10 a share. Why is this company being ignored by Wall Street, and what kind of gains could shareholders soon be looking at?

In my new video, I outline everything I believe is going to happen with this company. 
10/31/2022687,300 shares $1.34 million -3.0%N/A6 $1.95
10/15/2022708,800 shares $886,567.04 +5.6%N/A6.6 $1.25
9/30/2022671,500 shares $859,520.00 -19.7%N/A7.7 $1.28
9/15/2022836,600 shares $1.24 million -8.8%N/A7.1 $1.48
8/31/2022917,200 shares $1.91 million +4.2%N/A8.4 $2.08
8/15/2022880,400 shares $2.25 million +6.3%N/A7.9 $2.55
7/31/2022828,000 shares $2.05 million +8.7%N/A7 $2.48
7/15/2022761,800 shares $2.02 million 0.0%N/A6.7 $2.65
6/30/2022762,100 shares $1.87 million -1.3%N/A6.7 $2.45
6/15/2022771,900 shares $3.32 million +9.2%N/A7.5 $4.30
5/31/2022706,800 shares $2.78 million -12.9%N/A6.3 $3.94
5/15/2022811,200 shares $3.59 million +9.7%N/A7.1 $4.43
4/30/2022739,600 shares $3.75 million +1.4%N/A6.6 $5.07
4/15/2022729,200 shares $4.26 million +8.5%N/A6.1 $5.84
3/31/2022671,900 shares $4.65 million No ChangeN/A5.4 $6.92
3/15/2022671,900 shares $4.25 million +15.8%N/A5.5 $6.33
2/28/2022580,300 shares $5.38 million +1.2%N/A4.6 $9.27
2/15/2022573,200 shares $6.28 million +0.3%N/A4.8 $10.95
1/31/2022571,600 shares $7.23 million -14.5%N/A4.8 $12.65
1/15/2022668,800 shares $10.29 million +26.0%N/A6 $15.38
12/31/2021530,800 shares $8.44 million +5.2%N/A5.1 $15.90
12/15/2021504,400 shares $7.55 million -0.1%N/A5.1 $14.96
11/30/2021505,100 shares $9.34 million -0.8%N/A5.1 $18.50
11/15/2021509,300 shares $11.17 million -0.9%N/A5.4 $21.94
10/29/2021513,700 shares $12.78 million +15.5%N/A5.1 $24.87
10/15/2021444,700 shares $10.97 million -9.6%N/A4.4 $24.66
9/30/2021491,900 shares $9.86 million +45.3%N/A5.1 $20.05
9/15/2021338,500 shares $6.06 million +20.7%N/A3.4 $17.91
8/31/2021280,500 shares $7.83 million -27.5%N/A3.1 $27.92
8/13/2021387,100 shares $10.78 million -18.1%N/A4.4 $27.84
7/30/2021472,600 shares $14.20 million +0.3%N/A6 $30.05
7/15/2021471,000 shares $12.54 million +7.5%N/A5.5 $26.62
6/30/2021438,300 shares $13.53 million -11.3%N/A4.3 $30.86
6/15/2021494,100 shares $16.31 million -1.5%N/A4.8 $33.00
5/28/2021501,500 shares $16.53 million +2.6%N/A4.5 $32.96
5/14/2021488,700 shares $14.03 million +11.1%N/A3.6 $28.70
4/30/2021439,700 shares $13.09 million +11.7%N/A3.3 $29.78
4/15/2021393,600 shares $10.24 million +11.8%N/A2.7 $26.02
3/31/2021352,100 shares $8.98 million +14.1%N/A2.6 $25.50
3/15/2021308,600 shares $9.57 million +243.7%N/A2.3 $31.01
2/26/202189,800 shares $2.09 million -70.5%N/A0.8 $23.30
2/12/2021304,100 shares $7.92 million +225.9%N/A3 $26.03
1/29/202193,300 shares $2.36 million -69.4%N/A1 $25.33
1/15/2021305,200 shares $6.81 million No ChangeN/A3.7 $22.32

RNLX Short Interest - Frequently Asked Questions

What is Renalytix's current short interest?

Short interest is the volume of Renalytix shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 292,900 shares of RNLX short. Learn More on Renalytix's current short interest.

What is a good short interest ratio for Renalytix?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RNLX shares currently have a short interest ratio of 1.0. Learn More on Renalytix's short interest ratio.

Is Renalytix's short interest increasing or decreasing?

Renalytix saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 292,900 shares, an increase of 23.8% from the previous total of 236,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Renalytix's short interest compare to its competitors?

Here is how the short interest of companies compare to Renalytix: Personalis, Inc. (3.29%), Burning Rock Biotech Limited (0.46%), Enzo Biochem, Inc. (1.69%), Exagen Inc. (0.44%), Psychemedics Co. (0.24%), BioNexus Gene Lab Corp. (2.39%), OpGen, Inc. (2.37%), Fresh2 Group Limited (1.70%), Aclarion, Inc. (3.64%), DermTech, Inc. (9.50%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks.

What does it mean to sell short Renalytix stock?

Short selling RNLX is an investing strategy that aims to generate trading profit from Renalytix as its price is falling. RNLX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Renalytix?

A short squeeze for Renalytix occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RNLX, which in turn drives the price of the stock up even further.

How often is Renalytix's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RNLX, twice per month. The most recent reporting period available is June, 30 2024.



This page (NASDAQ:RNLX) was last updated on 7/13/2024 by MarketBeat.com Staff

From Our Partners